Comparison of outcomes of Taxol + Cisplatin and Taxol + Nedaplatin chemotherapy regimens for advanced non-small cell lung cancer.
- Author:
You-peng CAI
;
Shen XU
;
Shu-jun LIN
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Alopecia;
chemically induced;
Antineoplastic Combined Chemotherapy Protocols;
adverse effects;
therapeutic use;
Bone Neoplasms;
drug therapy;
pathology;
secondary;
Carcinoma, Non-Small-Cell Lung;
drug therapy;
pathology;
secondary;
Cisplatin;
adverse effects;
therapeutic use;
Humans;
Leukopenia;
chemically induced;
Liver Neoplasms;
drug therapy;
pathology;
secondary;
Lung Neoplasms;
drug therapy;
pathology;
Lymphatic Metastasis;
Middle Aged;
Neoplasm Staging;
Organoplatinum Compounds;
administration & dosage;
Paclitaxel;
administration & dosage;
Remission Induction;
Survival Rate;
Taxoids;
adverse effects;
therapeutic use;
Young Adult
- From:
Chinese Journal of Oncology
2010;32(1):74-75
- CountryChina
- Language:Chinese
